A previous study reported that neutrophils could acquire immunosuppressive characteristics in T cell-inflamed cancers, and the efficacy of cancer immunotherapies was improved via c-MET inhibition by impairing neutrophil mobilization and recruitment into tumors [44]. Here, MET is linked to cancer.